Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial-Reference-Cited by-同舟云学术

Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial

Published:2019-12-07 Issue:2 Volume:40 Page:207-216
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Naidu G. S. R. S. N. K.^ORCID,Sharma Shefali Khanna^ORCID,Adarsh M. B.^ORCID,Dhir Varun^ORCID,Sinha Anindita^ORCID,Dhooria Sahajal^ORCID,Jain Sanjay^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-019-04481-8.pdf

Reference37 articles.

1. Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A et al (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76:1897–1905. https://doi.org/10.1136/annrheumdis-2017-211448

2. Tyndal AJ, Banert B, Vonk M, Airò P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815. https://doi.org/10.1136/ard.2009.114264

3. Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208–219. https://doi.org/10.1016/j.semarthrit.2014.05.010

4. McNearney TA, Reveille JD, Fischbach M, Friedman AW, Lisse JR, Goel N Tan FK, Zhou X, Ahn C, Feghali-Bostwick CA, Fritzler M, Arnett FC, Mayes MD (2007) Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 57:318–326. https://doi.org/ 10.1002/art.22532

5. Dhooria S, Agarwal R, Sehgal IS, Prasad KT, Garg M, Bal A, Aggarwal AN, Behera D (2018) Spectrum of interstitial lung diseases at a tertiary center in a developing country: a study of 803 subjects. PLoS ONE 13:e0191938. https://doi.org/10.1371/journal.pone.0191938

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis;Seminars in Arthritis and Rheumatism;2024-10

2. Treatment of interstitial lung disease in systemic sclerosis: guidelines and new clinical trial results;Current Opinion in Rheumatology;2024-08-28

3. 2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis;Advances in Rheumatology;2024-07-10

4. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

5. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08